NuclixBio, Inc. is a company that places its focus on early-stage research and development of intracellularly targeted nucleic acid therapeutics, leveraging proprietary platform technologies. The company introduces innovative approaches, including the Circular mRNA platform and Aptamer-Drug Conjugates. NuclixBio, Inc. is a pioneer in the field of next-generation targeted therapeutics, aiming to address challenges in "Drugging ...
NuclixBio, Inc. is a company that places its focus on early-stage research and development of intracellularly targeted nucleic acid therapeutics, leveraging proprietary platform technologies. The company introduces innovative approaches, including the Circular mRNA platform and Aptamer-Drug Conjugates. NuclixBio, Inc. is a pioneer in the field of next-generation targeted therapeutics, aiming to address challenges in "Drugging the Undruggable." The company is composed of experts in nucleic acid engineering, and its mission is to explore unconventional paths in drug development.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.